GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF) » Definitions » Scaled Net Operating Assets

Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Scaled Net Operating Assets : -0.05 (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Santhera Pharmaceuticals Holding AG's operating assets for the quarter that ended in Jun. 2023 was $68.19 Mil. Santhera Pharmaceuticals Holding AG's operating liabilities for the quarter that ended in Jun. 2023 was $71.45 Mil. Santhera Pharmaceuticals Holding AG's Total Assets for the quarter that ended in Dec. 2022 was $68.41 Mil. Therefore, Santhera Pharmaceuticals Holding AG's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was -0.05.


Santhera Pharmaceuticals Holding AG Scaled Net Operating Assets Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Scaled Net Operating Assets Chart

Santhera Pharmaceuticals Holding AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.46 0.50 0.25 -0.01

Santhera Pharmaceuticals Holding AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.28 0.15 -0.01 -0.05

Competitive Comparison of Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets falls into.



Santhera Pharmaceuticals Holding AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2022 )
=(Operating Assets (A: Dec. 2022 )-Operating Liabilities (A: Dec. 2022 ))/Total Assets (A: Dec. 2021 )
=(66.953-67.599)/98.933
=-0.01

where

Operating Assets(A: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=68.405 - 1.452
=66.953

Operating Liabilities(A: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=115.298 - 23.279 - 24.42
=67.599

Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2023 )
=(Operating Assets (Q: Jun. 2023 )-Operating Liabilities (Q: Jun. 2023 ))/Total Assets (Q: Dec. 2022 )
=(68.193-71.446)/68.405
=-0.05

where

Operating Assets(Q: Jun. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=70.052 - 1.859
=68.193

Operating Liabilities(Q: Jun. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=117.544 - 21.679 - 24.419
=71.446

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Santhera Pharmaceuticals Holding AG Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Business Description

Traded in Other Exchanges
Address
Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.